Fadime Demir
Kayseri, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dose-Response and survival analysis after transarterial radioembolization for intrahepatic cholangiocarcinoma: A multicenter multicompartment dosimetry study.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 22, 2026
Quantitative Imaging Evaluation of Structural and Densitometric Changes in Major Salivary Glands After 177Lu PSMA Radioligand Therapy.
Journal: Annals of nuclear medicine
Published: April 17, 2026
Tc-99m DMSA Radiomics in CKD: Phenotype-Specific Cortical Signatures and a Morphological Predictor of Renal Function Decline.
Journal: Diagnostics (Basel, Switzerland)
Published: March 23, 2026
Renal and Hematologic Toxicity Profile of [177] Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT): A Retrospective Cohort Study.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: December 10, 2025
Renal and Hematologic Toxicity Profile of [177] Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT): A Retrospective Cohort Study.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: December 10, 2025
Can 68Ga-PSMA-11 PET/CT renal uptake parameters predict renal function impairment?
Journal: International urology and nephrology
Published: August 03, 2025
Predictive value of 18F-FDG PET/CT tumor SUVmax value in terms of overall survival after neoadjuvant therapy in rectal cancer.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: October 01, 2024
An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer.
Journal: Current radiopharmaceuticals
Published: February 04, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026